Integrative Medicine Institute

Spiritual assessment in mental health care: a review of current practices and future directions

Spirituality plays an increasingly recognised role in psychiatric recovery, resilience, and meaning-making. This article reviews the rationale, tools, challenges, and ethical imperatives for integrating spiritual assessment into psychiatric care. A literature review was conducted...

Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation

Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling, often irreversible toxicity that affects millions of patients, limits life-saving cancer therapy, and lacks proven treatment. In this work, we show that as little as two doses of psilocybin before chemotherapy dura...

Nanobodies specific for Vβ11 enable detection and noninvasive imaging of antigen-specific T cells in vivo

Through screening of a VHH phage display library constructed from an alpaca immunized with the recombinantly expressed murine myelin oligodendrocyte (MOG)-specific 2D2 T cell receptor (TCR), we identified nanobodies that reduced antigen-driven 2D2 T cell activation in vitro. Immu...

Structure‐Engineered Nanoporous Vanadium Oxide Memristors for Reconfigurable Synapse–Neuron Integration and Synergistic Robotic Motion

ABSTRACT Neuromorphic sensory‐to‐motor interfaces require compact devices that can combine nonvolatile synaptic weight storage with volatile neuronal firing, yet these functions typically rely on distinct material and circuit mechanisms. Here, we report a structure‐engineered VO...

Graphitic Grain‐Network Nanoarchitecture for Ultrahigh‐Rate and Exceptionally Durable Potassium Ternary Intercalation

ABSTRACT Potassium–ternary graphite intercalation compounds (K + ‐T‐GICs) are promising high‐power potassium‐ion storage materials, but their low reversible capacity and poorly understood electrolyte‐dependent behavior have limited their practical viability. Herein, this sensitiv...

Comparative study of the efficacy and safety of Ranquilon and Afobazol in the treatment of patients with anxiety associated with neurasthenia and adjustment disorders. (Results of an open, randomized, multicenter, phase IV clinical study)

Objective. To evaluate the efficacy and safety of Ranquilon1 at 6 mg daily, compared with Afobazol (fabomotizole) at 30 mg daily, for the treatment of patients with anxiety associated with neurasthenia and adjustment disorders. Material and methods. The clinical study included 20...